| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $60.9M | +17.5% |
| R&D Expense | $311.6M | -19.5% |
| SG&A Expense | $87.8M | +53.4% |
| Operating Income | -$338.5M | +13.8% |
| Pre-tax Income | -$260.2M | +29.8% |
| Income Tax | $3.4M | — |
| Net Income | -$289.1M | +22.0% |
| EPS (Basic) | -$4.13 | +28.4% |
| EPS (Diluted) | -$4.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.8M | -58.4% |
| Current Assets | $1.09B | -14.1% |
| Total Assets | $1.34B | -9.0% |
| Current Liabilities | $223.6M | +4.8% |
| Total Liabilities | $608.2M | -6.1% |
| Stockholders' Equity | $733.5M | -11.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.5M | +134.0% |
| Capital Expenditures | $49.0M | +4.6% |
| Investing Cash Flow | -$461.3M | -56.8% |
| Financing Cash Flow | $111.6M | -85.2% |
| Free Cash Flow | -$26.4M | +76.6% |
| +28.4% |